| Name | [2-[(8S,9S,10R,11S,13S,14S)-11-hydroxy-10,13-dimethyl-3-oxo-6,7,8,9,11,12,14,15-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate |
|---|---|
| Synonyms |
1,3-dimethyl-27-nitrosourea
Budesonide iMpurit 15 21-Acetoxy-112-hydroxypregna-1,4,16-triene-3,20-dione Intermediate of Budesonide 11beta,21-dihydroxypregna-1,4,16-triene-3,20-dione 21-acetate Budesonide triene Budesonide Impurity 15 Budesonide Impurity 57 Budesonide Impurity 38 (Budesonide Intermediate 3) Budesonide Impurity 32 (11b)-21-(Acetyloxy)-11-hydroxypregna-1,4,16-triene-3,20-dione 21-acetoxy-11β-hydroxypregna-1,4,16-triene-3,20-dione Budesonide 1,4,16-Triene Impurity (11|A)-11-hydroxy-3,20-dioxopregna-1,4,16-trien-21-yl acetate 2-((8S,9S,10R,11S,13S,14S)-11-hydroxy-10,13-dimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15-decahydro-3H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl acetate 21-Acetyloxy-11β-hydroxypregna-1,4,16-triene-3,20-dione Deoxyprednisolone-16-Ene Acetate [2-[(8S,9S,10R,11S,13S,14S)-11-Hydroxy-10,13-Dimethyl-3-Oxo-6,7,8,9,11,12,14,15-Octahydrocyclopenta[a]Phenanthren-17-Yl]-2-Oxoethyl] Acetate Budesonide Impurity 3 Budesonide Impurity 3/(11)-21-(Acetyloxy)-11-hydroxypregna-1,4,16-triene-3,20-dione 11β,21-dihydroxypregna-1,4,16-triene-3,20-dione 21-acetate Pregna-1,4,16-triene-3,20-dione, 21-(acetyloxy)-11-hydroxy-, (11β) Pregna-1,4,16-triene-3,20-dione,21-(acetyloxy)-11-hydroxy-, (11b) Budesonide intermediate Budesonide Impurity 22 21-Acetoxy-11b-hydroxypregna-1,4,16-triene-3,20-dione 21-acetoxy-11β-hydroxyl-1,4,16-pregnatriene-3,20-dione |
| Density | 1.24g/cm3 |
|---|---|
| Boiling Point | 553.4ºC at 760mmHg |
| Molecular Formula | C23H28O5 |
| Molecular Weight | 384.46500 |
| Flash Point | 189.9ºC |
| Exact Mass | 384.19400 |
| PSA | 80.67000 |
| LogP | 2.93360 |
| Index of Refraction | 1.584 |
| Hazard Codes | Xi |
|---|
|
~88%
3044-42-6 |
| Literature: Florida Agricultural and Mechanical University Patent: US4762919 A1, 1988 ; |
|
~78%
3044-42-6 |
| Literature: Schering Aktiengesellschaft Patent: US4290963 A1, 1981 ; |
|
~%
3044-42-6 |
| Literature: Green, Michael J.; Tiberi, Robert L.; Friary, Richard; Lutsky, Barry N.; Berkenkoph, Joseph; et al. Journal of Medicinal Chemistry, 1982 , vol. 25, # 12 p. 1492 - 1495 |
|
~%
3044-42-6 |
| Literature: Green, Michael J.; Tiberi, Robert L.; Friary, Richard; Lutsky, Barry N.; Berkenkoph, Joseph; et al. Journal of Medicinal Chemistry, 1982 , vol. 25, # 12 p. 1492 - 1495 |
|
~%
3044-42-6 |
| Literature: Taraporewala; Kim; Heiman; Lee Arzneimittel-Forschung/Drug Research, 1989 , vol. 39, # 1 p. 21 - 25 |
|
~%
3044-42-6 |
| Literature: Yoon, Kyoung-Jin; Khalil, Mounir A.; Kwon, Taesoo; Choi, Sun-Ju; Lee, Henry J. Steroids, 1995 , vol. 60, # 7 p. 515 - 521 |
| Precursor 5 | |
|---|---|
| DownStream 1 | |